Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia von Shanafelt, Tait D, Wang, Xin V, Kay, Neil E, Hanson, Curtis A, O’Brien, Susan, Barrientos, Jacqueline, Jelinek, Diane F, Braggio, Esteban, Leis, Jose F, Zhang, Cong C, Coutre, Steven E, Barr, Paul M, Cashen, Amanda F, Mato, Anthony R, Singh, Avina K, Mullane, Michael P, Little, Richard F, Erba, Harry, Stone, Richard M, Litzow, Mark, Tallman, Martin

Volltext

Long-term outcomes for ibrutinib-rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial von Shanafelt, Tait D, Wang, Xin Victoria, Hanson, Curtis A, Paietta, Elisabeth M, O'Brien, Susan, Barrientos, Jacqueline, Jelinek, Diane F, Braggio, Esteban, Leis, Jose F, Zhang, Cong Christine, Coutre, Steven E, Barr, Paul M, Cashen, Amanda F, Mato, Anthony R, Singh, Avina K, Mullane, Michael P, Little, Richard F, Erba, Harry, Stone, Richard M, Litzow, Mark, Tallman, Martin, Kay, Neil E

Volltext

Cyclophosphamide, bortezomib and dexamethasone induction for newly diagnosed multiple myeloma: high response rates in a phase II clinical trial von Reeder, C B, Reece, D E, Kukreti, V, Chen, C, Trudel, S, Hentz, J, Noble, B, Pirooz, N A, Spong, J E, Piza, J G, Zepeda, V H J, Mikhael, J R, Leis, J F, Bergsagel, P L, Fonseca, R, Stewart, A K

Volltext

Clinical characteristics and outcomes of Richter transformation: experience of 204 patients from a single center von Wang, Yucai, Tschautscher, Marcella A, Rabe, Kari G, Call, Timothy G, Leis, Jose F, Kenderian, Saad S, Kay, Neil E, Muchtar, Eli, Van Dyke, Daniel L, Koehler, Amber B, Schwager, Susan M, Slager, Susan L, Parikh, Sameer A, Ding, Wei

Volltext

Comparison of reduced intensity conditioning regimens used in patients undergoing hematopoietic stem cell transplantation for myelofibrosis von Jain, Tania, Kunze, Katie L., Temkit, M’hamed, Partain, Daniel K., Patnaik, Mrinal S., Slack, James L., Khera, Nandita, Hogan, William J., Roy, Vivek, Noel, Pierre, Leis, Jose F., Sproat, Lisa Z., Fauble, Veena, Mesa, Ruben A., Palmer, Jeanne

Volltext

The efficacy of ibrutinib in the treatment of Richter syndrome von Tsang, Mazie, Shanafelt, Tait D., Call, Timothy G., Ding, Wei, Chanan-Khan, Asher, Leis, Jose F., Nowakowski, Grzegorz S., Bowen, Deborah, Conte, Michael, Schwager, Susan M., Slager, Susan L., Kay, Neil E., Hanson, Curtis A., Parikh, Sameer A.

Volltext

Proteomics Approach of Rapamycin Anti-Tumoral Effect on Primary and Metastatic Canine Mammary Tumor Cells In Vitro von Lainetti, Patrícia F, Leis-Filho, Antonio F, Kobayashi, Priscila E, de Camargo, Laíza S, Laufer-Amorim, Renee, Fonseca-Alves, Carlos E, Souza, Fabiana F

Volltext

IGH translocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomes von Fang, Hong, Reichard, Kaaren K., Rabe, Kari G., Hanson, Curtis A., Call, Timothy G., Ding, Wei, Kenderian, Saad S., Muchtar, Eli, Schwager, Susan M., Leis, Jose F., Chanan‐Khan, Asher A., Slager, Susan L., Braggio, Esteban, Smoley, Stephanie A., Kay, Neil E., Shanafelt, Tait D., Van Dyke, Daniel L., Parikh, Sameer A.

Volltext

Compromised stem cell mobilization following induction therapy with lenalidomide in myeloma von Paripati, H, Stewart, A K, Cabou, S, Dueck, A, Zepeda, V J, Pirooz, N, Ehlenbeck, C, Reeder, C, Slack, J, Leis, J F, Boesiger, J, Torloni, A S, Fonseca, R, Bergsagel, P L

Volltext

The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice von Parikh, Sameer A., Achenbach, Sara J., Call, Timothy G., Rabe, Kari G., Ding, Wei, Leis, Jose F., Kenderian, Saad S., Chanan‐Khan, Asher A., Koehler, Amber B., Schwager, Susan M., Muchtar, Eli, Fonder, Amie L., McCullough, Kristen B., Nedved, Adrienne N., Smith, Matthew D., Slager, Susan L., Kay, Neil E., Finnes, Heidi D., Shanafelt, Tait D.

Volltext

Outcomes of a large cohort of individuals with clinically ascertained high-count monoclonal B-cell lymphocytosis von Parikh, Sameer A, Chaffee, Kari G, Larson, Melissa C, Hampel, Paul J, Call, Timothy G, Ding, Wei, Kenderian, Saad S, Leis, Jose F, Chanan-Khan, Asher A, Conte, Michael J, Bowen, Deborah, Schwager, Susan M, Slager, Susan L, Hanson, Curtis A, Kay, Neil E, Shanafelt, Tait D

Volltext

Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome von Wang, Yucai, Sinha, Sutapa, Wellik, Linda E., Secreto, Charla R., Rech, Karen L., Call, Timothy G., Parikh, Sameer A., Kenderian, Saad S., Muchtar, Eli, Hayman, Suzanne R., Koehler, Amber B., Van Dyke, Daniel L., Leis, Jose F., Slager, Susan L., Dong, Haidong, Kay, Neil E., He, Rong, Ding, Wei

Volltext

Chronic lymphocytic leukemia and infection risk in the era of targeted therapies: Linking mechanisms with infections von Hilal, Talal, Gea-Banacloche, Juan C., Leis, Jose F.

Volltext

The role of 18F-FDG-PET in detecting Richter's transformation of chronic lymphocytic leukemia in patients receiving therapy with a B-cell receptor inhibitor von Wang, Yucai, Rabe, Kari G, Bold, Michael S, Shi, Min, Hanson, Curtis A, Schwager, Susan M, Call, Timothy G, Kenderian, Saad S, Muchtar, Eli, Hayman, Suzanne R, Koehler, Amber B, Fonder, Amie L, Chanan-Khan, Asher A, Van Dyke, Daniel L, Slager, Susan L, Kay, Neil E, Ding, Wei, Leis, Jose F, Parikh, Sameer A

Volltext

Chronic lymphocytic leukemia (CLL) with Reed–Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter? von King, Rebecca L., Gupta, Alia, Kurtin, Paul J., Ding, Wei, Call, Timothy G., Rabe, Kari G., Kenderian, Saad S., Leis, Jose F., Wang, Yucai, Schwager, Susan M., Slager, Susan L., Kay, Neil. E., Koehler, Amber, Ansell, Stephen M., Inwards, David J., Habermann, Thomas M., Shi, Min, Hanson, Curtis A., Howard, Matthew T., Parikh, Sameer A.

Volltext

Quality of the control arms in randomized trials of chronic lymphocytic leukemia enrolling in the USA: A systematic review von Hilal, Talal, Mohyudin, Adil, Ayala, Ruth, Almader-Douglas, Diana, Leis, Jose F.

Volltext

Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib von Hampel, Paul J., Rabe, Kari G., Call, Timothy G., Ding, Wei, Leis, Jose F., Chanan-Khan, Asher A., Kenderian, Saad S., Muchtar, Eli, Wang, Yucai, Ailawadhi, Sikander, Koehler, Amber B., Parrondo, Ricardo, Schwager, Susan M., Sher, Taimur, Hanson, Curtis A., Shi, Min, Van Dyke, Daniel L., Braggio, Esteban, Slager, Susan L., Kay, Neil E., Parikh, Sameer A.

Volltext

Cause of death in patients with newly diagnosed chronic lymphocytic leukemia (CLL) stratified by the CLL-International Prognostic Index von Wang, Yucai, Achenbach, Sara J., Rabe, Kari G., Shanafelt, Tait D., Call, Timothy G., Ding, Wei, Kenderian, Saad S., Muchtar, Eli, Leis, Jose F., Koehler, Amber B., Schwager, Susan M., Cerhan, James R., Slager, Susan L., Kay, Neil E., Parikh, Sameer A.

Volltext

Immunoablation and Stem Cell Transplantation in Amyotrophic Lateral Sclerosis: The Ultimate Test for the Autoimmune Pathogenesis Hypothesis von Leis, A Arturo, Ross, Mark A, Verheijde, Joseph L, Leis, Jose F

Volltext

Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL von Ding, Wei, LaPlant, Betsy R., Call, Timothy G., Parikh, Sameer A., Leis, Jose F., He, Rong, Shanafelt, Tait D., Sinha, Sutapa, Le-Rademacher, Jennifer, Feldman, Andrew L., Habermann, Thomas M., Witzig, Thomas E., Wiseman, Gregory A., Lin, Yi, Asmus, Erik, Nowakowski, Grzegorz S., Conte, Michael J., Bowen, Deborah A., Aitken, Casey N., Van Dyke, Daniel L., Greipp, Patricia T., Liu, Xin, Wu, Xiaosheng, Zhang, Henan, Secreto, Charla R., Tian, Shulan, Braggio, Esteban, Wellik, Linda E., Micallef, Ivana, Viswanatha, David S., Yan, Huihuang, Chanan-Khan, Asher A., Kay, Neil E., Dong, Haidong, Ansell, Stephen M.

Volltext